Pfizer tacks $80m onto ResApp offer

14/06/2022 - 11:10

Bookmark

Upgrade your subscription to use this feature.

Pfizer and WA-founded med-tech business ResApp have agreed to an increased cash takeover offer following a reappraisal of the target’s share price.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options